Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia
| 対象疾患 | Alzheimer's Disease |
|---|---|
| 相 | 該当なし |
| スポンサー | Icahn School of Medicine at Mount Sinai |
| ステータス | 完了 |
| 参加者数 | 14 名 |
| 介入（薬剤） | Active lighting intervention, Control lighting intervention |
| 開始日 | 2022年1月6日 |
| 完了日 | 2023年5月1日 |
| 結果公開日 | 2026年7月30日 |
概要
To test the effect of a tailored lighting intervention controlled by the Readings At Desk (RAD) controller on sleep and mood in Alzheimer's disease participants.
Sleep Disturbance Using the Pittsburgh Sleep Quality Index (PSQI)
| Active Lighting Intervention | 6.5 ± 4.3 Score on a scale |
|---|---|
| Control Lighting | 4 ± 2.3 Score on a scale |
| Active Lighting Intervention | 4.1 ± 2.3 Score on a scale |
| Control Lighting | 6 ± 3.3 Score on a scale |
BENITIONS で見る ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Wake Forest University Health Sciences
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Eli Lilly and Company
- Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges — Brigham and Women's Hospital
- Technology and Family Thriving Study — University of California, Santa Barbara
- Community-based Brain Health Program to Address Dementia Risk — Posit Science Corporation
- Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzhei — Georgetown University